Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Grossman

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Neuroendocrinology|June 5, 2020
Preface to Update on Parasellar Tumours: ENEA Workshop, Athens, December 6-7, 2019Ashley Grossman
The Lancet. Diabetes & Endocrinology|October 17, 2017
Is the new treatment for Cushing's disease too sweet?Ashley Grossman
Endocrine|September 13, 2015
Assessment of the HPA Axis: Another New Test?Ashley Grossman
Endocrine|March 3, 2018
Predicting an adrenal crisis: can we do it?Ashley Grossman
The Lancet. Diabetes & Endocrinology|March 14, 2014
The nuclear option for insulinomasAshley Grossman
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2016
Somatic and germline mutations in NETs: Implications for their diagnosis and managementMarianna Minnetti, Ashley Grossman
Expert Opinion on Therapeutic Targets|February 1, 2011
The molecular pathogenesis and management of bronchial carcinoidsMehtap Cakir, Ashley Grossman
Endokrynologia Polska|May 9, 2013
The management of Cushing's disease - from investigation to treatmentAgata Juszczak, Ashley Grossman
Clinical Endocrinology|March 5, 2013
Glucocorticoid-induced osteoporosis: lessons from Cushing's syndromeMiklós Tóth, Ashley Grossman
Neuroendocrinology|October 24, 2018
Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide TherapyShaunak Navalkissoor, Ashley Grossman
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Neuroendocrinology|June 5, 2020
Preface to Update on Parasellar Tumours: ENEA Workshop, Athens, December 6-7, 2019Ashley Grossman
The Lancet. Diabetes & Endocrinology|October 17, 2017
Is the new treatment for Cushing's disease too sweet?Ashley Grossman
Endocrine|September 13, 2015
Assessment of the HPA Axis: Another New Test?Ashley Grossman
Endocrine|March 3, 2018
Predicting an adrenal crisis: can we do it?Ashley Grossman
The Lancet. Diabetes & Endocrinology|March 14, 2014
The nuclear option for insulinomasAshley Grossman
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2016
Somatic and germline mutations in NETs: Implications for their diagnosis and managementMarianna Minnetti, Ashley Grossman
Expert Opinion on Therapeutic Targets|February 1, 2011
The molecular pathogenesis and management of bronchial carcinoidsMehtap Cakir, Ashley Grossman
Endokrynologia Polska|May 9, 2013
The management of Cushing's disease - from investigation to treatmentAgata Juszczak, Ashley Grossman
Clinical Endocrinology|March 5, 2013
Glucocorticoid-induced osteoporosis: lessons from Cushing's syndromeMiklós Tóth, Ashley Grossman
Neuroendocrinology|October 24, 2018
Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide TherapyShaunak Navalkissoor, Ashley Grossman
Pageof 14